Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5606
Peer-review started: June 2, 2020
First decision: June 12, 2020
Revised: June 30, 2020
Accepted: September 16, 2020
Article in press: September 16, 2020
Published online: October 7, 2020
Processing time: 117 Days and 9 Hours
Several studies have shown a significant adenoma miss rate up to 35% during screening colonoscopy, especially in patients with diminutive adenomas. The use of artificial intelligence (AI) in colonoscopy has been gaining popularity by helping endoscopists in polyp detection, with the aim to increase their adenoma detection rate (ADR) and polyp detection rate (PDR) in order to reduce the incidence of interval cancers. The efficacy of deep convolutional neural network (DCNN)-based AI system for polyp detection has been trained and tested in ex vivo settings such as colonoscopy still images or videos. Recent trials have evaluated the real-time efficacy of DCNN-based systems showing promising results in term of improved ADR and PDR. In this review we reported data from the preliminary ex vivo experiences and summarized the results of the initial randomized controlled trials.
Core Tip: The use of artificial intelligence (AI) in colonoscopy has been gaining popularity in current times. At first, the efficacy of deep convolutional neural network (DCNN)-based AI system for polyp detection has been tested in ex vivo settings such as still images or videos from colonoscopies. Recent trials have evaluated the real-time efficacy of DCNN-based systems in improving adenoma detection rate and polyp detection rate. In this review we reported all the preliminary ex vivo experiences and summarized the promising results of the initial randomized controlled trials.